Eli Lilly pays record $1.4bn for promoting off-label use of olanzapine.
Kmietowicz
Zosia
Z
D001569:Benzodiazepines / Q000191:economics*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D004348:Drug Labeling; D006801:Humans; D008389:Marketing of Health Services / Q000191:economics* / Q000331:legislation & jurisprudence; D000077152:Olanzapine; D014481:United States
D001569:Benzodiazepines; D000077152:Olanzapine